
Sign up to save your podcasts
Or


Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.
By American Academy of Neurology4.7
1919 ratings
Neurology Today Editor-in-Chief Joseph E. Safdieh, MD, FAAN, highlights new articles that discuss program directors' response to the use of generative AI for personal statements, the good news for neurology based on the 2024 Match Day, and the AHS statement on CGRP-targeting therapies as a game changer for migraine treatment.

138 Listeners

323 Listeners

498 Listeners

297 Listeners

46 Listeners

13 Listeners

191 Listeners

95 Listeners

515 Listeners

137 Listeners

369 Listeners

190 Listeners

375 Listeners

6 Listeners

83 Listeners